# Bileacid Malabsorption and GLP-1 Secretion

> **NCT03009916** · PHASE4 · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 24 (actual)

## Conditions studied

- Bileacid Malabsorption

## Interventions

- **DRUG:** "cholestagel®" (Colesevelam)
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03009916
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-08-03
- **Final completion:** 2017-08-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009916, "Bileacid Malabsorption and GLP-1 Secretion". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03009916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*